3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
22
Squamous Cell Carcinoma of Head and Neck
13
Carcinoma, Non-Small-Cell Lung
12
Neoplasms
6
Rectal Neoplasms
5
Neoplasm Metastasis
5
Mouth Neoplasms
5
Lung Neoplasms
5
Head and Neck Neoplasms
5
Colonic Neoplasms
5
Pancreatic Neoplasms
4
Laryngeal Neoplasms
3
Hypopharyngeal Neoplasms
3
Carcinoma, Squamous Cell
3
Carcinoma
3
Thyroid Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Endometrial Neoplasms
2
Urologic Neoplasms
1
Solid Tumors
1
Soft Tissue Neoplasms
1
Skin Neoplasms
1
Sarcoma
1
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pharyngeal Neoplasms
1
Neurofibromatosis 2
1
Neurofibromatosis 1
1
Interventions
Temozolomide
18
Radiation
7
Magnetic Resonance Spectroscopy
7
Radiotherapy
6
Specimen Handling
4
Lomustine
4
Bevacizumab
4
Aminolevulinic Acid
3
veliparib
2
trametinib
2
lutetium Lu 177 dotatate
2
dabrafenib
2
azeliragon
2
Surgical Procedures, Operative
2
Receptors, Interleukin-8B
2
Nivolumab
2
D2C7-(scdsFv)-PE38KDEL
2
Carboplatin
2
Biopsy
2
varlilumab
1
ulixertinib
1
tinostamustine
1
selinexor
1
ruxolitinib
1
ribociclib
1
relatlimab
1
regorafenib
1
peposertib
1
pembrolizumab
1
olaparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Glioblastoma
×
Cetuximab
×
30 days
×
Clear all
No trials found.